News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, December 31, 2018

UPDATE!   Don’t miss out!  ORA/GCA/Purchasing Workshop

Ever wondered who we are and what we do?

Ever needed help with a grant submission?

Not quite sure how to support your faculty with their grants and contracts?

Are you struggling with a human subjects section of your proposal?

Are budget and compliance questions keeping you from your real job?

Finally the moment you’ve been waiting for….

We are pleased to announce a joint workshop, “The OUHSC World of Grants & Contracts” for

faculty and staff.  This workshop will offer a one-day training on sponsored research topics. 

The sessions are the same for both days, just different times.  The information will be provided

in a variety of formats ranging from talks to breakout sessions with experts sitting at tables eager

to answer all your questions.

WHEN:  January 8 and 10, 2019

Agendas and Overviews are attached.

Registration Link: https://ouhsc.qualtrics.com/jfe/form/SV_brNbPux1ZHPNzxP

https://research.ouhsc.edu/Portals/1329/Assets/Documents/January 8 2019 Agenda_The OUHSC World of Grants Contracts Workshop_updated.docx?ver=2018-12-20-121306-083

https://research.ouhsc.edu/Portals/1329/Assets/Documents/January 10 2019 Agenda_The OUHSC World of Grants Contracts Workshop_updated.docx?ver=2018-12-20-121306-100

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Workshop Session Overviews_updated.docx?ver=2018-12-20-121306-083

 

Resources for Rigorous Research
Mike Lauer, MD, NIH Deputy Director for Extramural Research, describes new resources provided

by the NIH to facilitate rigorous research in an Open Mike blog post A revamped Rigor and

Reproducibility Webpage has been updated with new policies and new resources, none of which

have new requirements or forms. Additionally, past confusion about the meaning of “scientific

premise” in grant applications inspired the NIH to replace this term with “rigor of the prior research”

under the Significance section of most research grant and career development award applications

for applications due on and after January 25, 2019.

https://www.nih.gov/research-training/rigor-reproducibility

 

 

The National Science Foundation (NSF) has adopted a new term and condition,

which is incorporated into its Agency Specific Requirements to Research Terms and Conditions,

Grant General Terms and Conditions, and Cooperative Agreement/Financial and Administrative

Terms and Conditions. The new term and condition reflects NSF’s stated position that it will

NOT tolerate harassment, including sexual harassment, other forms of harassment, and

sexual assault, within the agency, at awardee organizations, at field sites, or anywhere

NSF-funded science and education is conducted. 

This position is consistent with the University of Oklahoma’s commitment to creating and maintaining

a community where all persons who participate in University programs and activities can work and

learn together in an atmosphere free from all forms of harassment, exploitation, or intimidation. The

University condemns sexual harassment, sexual assault, sexual misconduct, and discrimination based

on sex. Any such activity committed by a member of the University community may subject the

individual to University sanctions.

The new NSF term and condition requires the University, as an awardee organization, to notify NSF of:

·        Any findings or determination that demonstrates that an NSF-funded principal investigator or

co-principal investigator violated laws or University policies related to sexual harassment, other forms

of harassment, or sexual assault. 

·        The placement of an NSF-funded principal investigator or co-principal investigator on administrative l

eave or of the imposition of any administrative action against either of them relating to findings,

determination, or investigation of an alleged violation of law or University policies pertaining to sexual

harassment, other forms of harassment, or sexual assault finding or investigation.

The reporting requirement is effective for any new NSF awards or funding amendments to existing NSF

awards made on or after October 21, 2018. As provided in the University’s policies, if you experience or

become aware of sexual harassment, other forms of harassment, or sexual assault by anyone, including

an NSF-funded PI or co-PI, please contact the Equal Opportunity office on your campus.

A revised set of Frequently Asked Questions (FAQs) (see attached document) regarding NSF’s Award

Term and Condition Entitled, “Notification Requirements Regarding Sexual Harassment, Other Forms of

Harassment, or Sexual Assault” has been posted to the Office of Diversity and Inclusion’s harassment

website.  These revised FAQS are dated December 4, 2018, and include 16 additional questions and

responses.

For additional information, visit the NSF Sexual Harassment and the OU Institutional Equity Office

websites.  Please contact Faustina Layne, faustina-layne@ouhsc.edu with questions.

https://www.nsf.gov/od/odi/harassment.jsp

https://research.ouhsc.edu/Portals/1329/Assets/Documents/NSF_Sexual_Harassment_FAQs (7).pdf?ver=2019-01-02-074034-323

 

Oklahoma Center for Adult Stem Cell Research (OCASCR) 

EXPANSION OF AREA OF FUNDING - Call for Applications – Due January 18, 2019

OCASCR has expanded the applications it will accept for funding to include, in addition to adult

stem cell research projects, research in regenerative medicine - a field that is closely related to

adult stem cell biology and that strives to restore the normal functions of cells, tissues, and organs

that have been damaged by disease.  For applications focused on regenerative medicine, those

projects related to diseases caused by smoking or obesity (i.e. cancer, cardiovascular disease,

diabetes, etc.) will be prioritized.  Additional information on this Call for Applications and links to

grant application forms and instructions can be found at: http://www.ocascr.org/grants/

 

 

**ATTENTION iRIS USERS:

The Revised Common Rule is quickly approaching (1/21/2019)!

See the attached HRPP announcement for a list of key changes and important dates!

These dates not only affect your new study submissions, but also your access to iRIS in January 2019.

See attached document for additional information.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/HRPP Announcement - Revised Common Rule and iRIS Transition Plan.pdf?ver=2018-12-17-073357-027

 

Call for Applications: 2019-2020 Awards Supported by the San Antonio Nathan Shock

Center

The San Antonio Nathan Shock Center is soliciting applications to support the research of any

investigator who is developing a new project in the basic biology of aging.  Applications are

accepted from investigators at any US academic institution.  Junior investigators are encouraged

to apply. We can consider applications from any investigator who is eligible to receive NIH grants

according to the rules of their home institution. The projects should utilize one or more Cores of the

Center. Projects that propose creative uses of more than one Core are encouraged. Awards will be

made for the next budget year (July 1 2019 to June 30 2020). Funds will be allocated for Core services.

Only under very unusual circumstances and careful justification will we consider awarding funds directly

to the PI’s lab. Applications are due January 15, 2019.  For additional information go to:

https://nathanshock.barshop.uthscsa.edu/rfa-support-core-service/

 

 

The Graduate College is now receiving applications for the 2019 Summer Undergraduate

Research Programs at the University of Oklahoma Health Sciences Center.  There are four

separate programs: the Summer Undergraduate Research Experience (SURE), the Native American

Research Centers for Health (NARCH), The Oklahoma IDeA Network of Biomedical Research

Excellence (OK-INBRE), and the Cancer Undergraduate Research Experience (CURE) Summer

Programs. Again this year, approximately 60 students will be hosted in labs on the OUHSC campus

and across the OK-INBRE network. All participants will receive valuable research experience, be

given the chance to present their summer projects at a poster competition, and receive a generous

stipend.

The deadline to apply is February 5th, 2019.

The online application and additional information about these programs are on the SURP website,

below.

https://graduate.ouhsc.edu/Research/Summer-Undergraduate-Programs

 

 

OK-INBRE Research Project Investigator (RPI) Program

Proposal deadline: February 22, 2019

Call for proposals:

https://okinbre.ouhsc.edu/Funding-Opportunities/Funding-Opportunities-for-OUHSC-and-OMRF

The Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) is requesting

applications for Research Project Investigator Awards (RPI).  The program seeks to support

proposals designed to generate preliminary data that enhances the competitiveness of the

OUHSC/OMRF investigators for future extramural funding.  The proposed project must align

with one of the biomedical research themes of the OK-INBRE program: Cancer, Developmental

Biology or Infectious Diseases.  The RPI project period is 2 ½ years in duration funded at

$100,000 in direct costs per year.  Selected projects will commence in May 2019.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/COBRE Pilot Application DevBio.docx?ver=2018-12-03-073329-093

 

ORAU-Directed Research and Development (ODRD) Program

The FY 2019 competition for collaborative awards of up to $75,000 to be shared between the

university and ORAU researchers is now open. We anticipate and expect that these seed funds

will position the collaborative teams to be more competitive for new, external funding opportunities.

The deadline for joint ORAU/university proposals is March 25, 2019 and potential university partners

are encouraged to submit concepts for discussion with ORAU partners as soon as possible. 

https://www.orau.org/university-partnerships/member-grant-programs/odrd.html

 

 

NIH NOTICES

 

Notice of Interest in Long-Term Maintenance of Behavior Change Research (NOT-OD-19-040)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-040.html

 

Notice of Intent to Publish Funding Opportunity Announcements for Research to Develop,

Demonstrate, and Validate Experimental Human Tissue Models that Do Not Rely on Human Fetal

Tissue (NOT-OD-19-042)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-042.html

 

Advance Notice: Streamlining the Certifications and Representations Process and Phasing Out the

SF-424B (NOT-OD-19-043)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-043.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Administrative Supplements

for Research on Bioethical Issues (NOT-OD-19-045)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-045.html

 

Notice of Change to PAR-18-319 "HIV Vaccine Research and Design (HIVRAD) Program

(P01 Clinical Trial Not Allowed)" (NOT-AI-19-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-016.html

 

Notice of Pre-Application Webinars for the HEAL Initiative: Back Pain Consortium (BACPAC)

Research Program (NOT-AR-19-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-031.html

 

Notice of Additional Funds Available for PAS-18-625, " Mechanistic Investigations of Psychosocial

Stress Effects on Opioid use Patterns (R21- Clinical Trial Optional)" (NOT-DA-18-049)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-049.html

 

HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research

on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (NOT-DA-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-003.html

 

Notice of NIBIB's Participation in PA-18-817 "Administrative Supplements for Research on Dietary

Supplements (Admin Supp - Clinical Trial Not Allowed)" (NOT-EB-18-034)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-18-034.html

Notice of NIBIB's Participation in PAR-19-093 "Leveraging Health Information Technology (Health IT)

to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)" (NOT-EB-18-035)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-18-035.html

 

Notice of Change to Requirement for Letter of Support from the Applicant Institution's Authorized

Organizational Representative in PAR-17-094 "Maximizing Investigators' Research Award (R35)"

(NOT-GM-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-008.html

 

NHLBI Accepts Only Investigator-Initiated Clinical Trial Applications Proposing Mechanistic Studies

and Basic Experimental Studies Involving Humans (BESH) in Response to the NIH Parent R01

Clinical Trial Required Announcement (NOT-HL-18-662)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-662.html

 

NHLBI Accepts Investigator-Initiated Basic Experimental Studies Involving Humans (BESH) that

Meet NIHs Definition of a Clinical Trial only in Response to PA-18-345 NIH Research Project Grant

(Parent R01 Clinical Trial Required) (NOT-HL-18-663)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-663.html

 

NHLBI Announces Plan to Fund a Limited MESA Exam 7 (NOT-HL-18-668)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-668.html

 

NHLBI Announces Participation in RFA-OD-19-013 "Specialized Centers of Research Excellence

(SCORE) on Sex Differences (U54 Clinical Trial Optional)" (NOT-HL-18-669)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-669.html

 

Notice of Changes in the Eligibility of Candidates and Budget Supported by the NIMH Administrative

Supplement Program to Enable Continuity of Research Experiences of MD/PhDs During Clinical

Training (Admin Supp) (NOT-MH-18-074)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-074.html

 

Notice of Information: NIMH Priorities for Research to Inform Stepped-Care Interventions for

Persons at Clinical High Risk for Psychosis (NOT-MH-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-003.html

 

Notice of Expiration of PA-18-471 "Innovative Questions in Symptom Science and Genomics

(R15 Clinical Trial Not Allowed)" (NOT-NR-18-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-022.html

 

Notice of Expiration of PA-18-475 " Community Partnerships to Advance Research (CPAR)

(R15 Clinical Trial Not Allowed)" (NOT-NR-18-024)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-022.html

 

HEAL Initiative: Notice of Interest in Small Business Innovation Research (SBIR) and Small Business

Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved

Treatments for Opioid Misuse and Addiction (NOT-NS-19-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-014.html

 

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PA-18-705

(NOT-NS-19-023)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-023.html

 

Notice of NINDS' Participation in NOT-AG-18-050 "Notice to Specify High-Priority Research

Topic for PAR-19-070" (NOT-NS-19-025)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-025.html

 

HEAL Initiative: Announcement of the NCATS ASPIRE Design Challenges to Develop Innovative

and Catalytic Approaches Towards Solving the Opioid Crisis (NOT-TR-18-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-18-031.html

 

Notice of Change to FOA (RFA-OD-19-013) "Specialized Centers of Research Excellence (SCORE)

on Sex Differences (U54 Clinical Trial Optional)" (NOT-OD-19-044)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-044.html

 

Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071 (NOT-AG-18-053)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-053.html

 

Notice of Correction to Advisory Council Review Dates for PAR-19-070 and PAR-19-071, "Research

on Current Topics in Alzheimer's Disease and Its Related Dementias" (NOT-AG-18-054)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-054.html

 

Clarification of the Award Period for NOT-AG-18-039, "Alzheimer's-Focused Administrative

Supplements for NIH Grants that are not Focused on Alzheimer's Disease" (NOT-AG-18-055)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-055.html

 

Notice of Change in Expiration Date of PA-17-278 "HIV and Hepatitis B Co-Infection: Advancing

HBV Functional Cure through Clinical Research (R21)" (NOT-AI-19-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-018.html

 

Notice of Change in Expiration Date of PA-17-279 "HIV and Hepatitis B Co-Infection: Advancing

HBV Functional Cure through Clinical Research (R01)" (NOT-AI-19-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-019.html

 

Notice of Change in Expiration Date of PA-17-280 "In Vitro and Animal Model Studies on HBV/HIV

Co-Infection (R01)" (NOT-AI-19-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-020.html

 

Notice of Change in Expiration Date of PA-17-281 "In Vitro and Animal Model Studies on HBV/HIV

Co-Infection (R21)" (NOT-AI-19-021)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-021.html

 

Notice of Changes to PA-19-082, "Novel Approaches to Understand, Prevent, Treat, and Diagnose

Coccidioidomycosis (Valley Fever) and other Select Endemic Fungal Infections (R01 Clinical Trial

Not Allowed)" (NOT-AI-19-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-026.html

 

Notice of Changes to PA-19-083, "Novel Approaches to Understand, Prevent, Treat, and Diagnose

Coccidioidomycosis (Valley Fever) and other Select Endemic Fungal Infections (R21 Clinical Trial

Not Allowed)" (NOT-AI-19-027)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-027.html

 

Notice of Change in the Award Project Period section in PA-18-914, "Supplements to Advance Research

(STAR) from Projects to Programs" (NOT-AR-19-033)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-033.html

 

NCCIH Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent

R01 Announcements (NOT-AT-19-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-011.html

 

Notice of NCI Participation in RFA-AI-18-054, U.S.-Brazil Collaborative Biomedical Research Program

(R01 Clinical Trial Optional) (NOT-CA-19-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-014.html

 

Notice of NCI Participation in PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research

(R21 Clinical Trial Optional) (NOT-CA-19-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-015.html

 

Notice of Additional Funds Available for PAS-18-624, " Mechanistic Investigations of Psychosocial

Stress Effects on Opioid use Patterns (R01- Clinical Trial Optional)" (NOT-DA-18-048)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-048.html

 

Notice of Correction to Application Types Allowed for RFA-DA-19-019, "HEAL Initiative: Americas

Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial

Optional)" (NOT-DA-19-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-013.html

 

Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for

RFA-DA-19-025, RFA-DA-19-024, RFA-DA-19-023, " HEAL Initiative: Justice Community Opioid

Innovation Network (JCOIN)" (NOT-DA-19-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-014.html

 

Notice to Announce Webinar to Request Public Input on Upcoming Surgeon Generals Report on

Oral Health (NOT-DE-18-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-DE-18-031.html

 

Notice of Expiration for PA-18-495 Academic Research Enhancement Award in Diseases Within

the Mission of NIDDK (R15 Clinical Trial Required) (NOT-DK-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-19-005.html

 

NIDDK Will Participate in RFA-OD-19-012: Short Courses on Innovative Methodologies and Approaches

in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed) (NOT-DK-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-19-008.html

 

Notice of Change to Key Dates and Peer Review Contact for RFA-DK-18-001, Silvio O. Conte Digestive

Diseases Research Core Centers (P30 Clinical Trial Optional) (NOT-DK-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-19-009.html

 

Notice of Change in Key Dates for RFA-ES-18-009 "Maintain and Enrich Resource Infrastructure for

Existing Environmental Epidemiology Cohorts (R24 Clinical Trial Not Allowed)" (NOT-ES-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-19-005.html

 

Notice of NEI's participation in PAR-18-714, "Academic Research Enhancement Award for

Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)" (NOT-EY-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-EY-19-006.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for the Maximizing Investigators'

Research Award Program (NOT-GM-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-006.html

 

Notice of Clarification of Institutional Eligibility for PAR-19-037 "Initiative for Maximizing Student

Development (IMSD) (T32)" (NOT-GM-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-007.html

 

Notice of Change to Requirement for Letter of Support from the Applicant Institution's Authorized

Organizational Representative in PAR-17-190 "Maximizing Investigators' Research Award for Early

Stage Investigators (R35)" (NOT-GM-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-009.html

 

Notice of Consolidation and Additional Clarifications of Applications Relevant to PAR-17-046

"Exploratory Research for Technology Development (R21)" (NOT-GM-19-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-010.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Antenatal Opioid Exposure

Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed) (NOT-HD-18-021)
http://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-021.html

 

Notice of Intent to Publish Funding Opportunity Announcements for the Intellectual and Developmental

Disabilities Research Centers (IDDRC) (PM1 Clinical Trial Optional) (NOT-HD-18-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-030.html

 

Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 "Research Supplements to

Promote Diversity in Health-Related Research (NOT-HG-19-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-010.html

 

Notice of NHLBI Participation in PAR-19-135 "Research Enhancement Award Program (REAP) for

Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)" (NOT-HL-18-665)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-665.html

 

AHRQ Notice of Cancellation of PA 17-260 and PA 17-261 (NOT-HS-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-19-004.html

 

Notice of PA 15-179 and PA 16-420 Cancellation (NOT-HS-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-19-005.html

 

Notice of PA Cancellation: PA-15-180 (NOT-HS-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-19-006.html

 

Notice of NLM's Participation in PAR-19-093 "Leveraging Health Information Technology (Health IT)

to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)" (NOT-LM-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-LM-19-002.html

 

Notice of NIMHD Interest in Receiving Letters Requesting Permission to Submit Applications to

Support a Research Centers in Minority Institutions (RCMI) Program National Conference (U13)

(NOT-MD-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-19-002.html

 

NIMH Acceptance of Clinical Trial Applications under the Parent R01 and R21 Clinical Trial Required,

or Basic Experimental Studies Involving Humans (BESH) Announcements is Limited to Mechanistic

Clinical Trials (NOT-MH-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-006.html

 

Updates for RFA-MH-19-225, A Practice-Based Research Network to Transform Mental Health Care:

Science, Service Delivery & Sustainability (U19 Clinical Trial Required) (NOT-MH-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-007.html

 

Notice of NIMH Participation in PAR-18-714 " Academic Research Enhancement Award for

Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) (NOT-MH-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-009.html

 

Notice to update Application Types Allowed for PAR-18-763 "Innovation Grants to Nurture Initial

Translational Efforts (IGNITE): Development and Validation of Model Systems and/or

Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33) (NOT-NS-19-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-017.html

 

Notice of Interest in Advancing Research in Acute Flaccid Myelitis and Guillain-Barre Syndrome

(NOT-NS-19-029)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-029.html

 

Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial

Optional) (NOT-TR-19-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-19-013.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) (RFA-AA-19-003)

Deadline April 16, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-19-003.html

 

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Mechanistic Research

Centers (U19 Clinical Trial Optional) (RFA-AR-19-026) – Deadline March 20, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-026.html

 

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm

Development and Operations Management Center (U24 Clinical Trial Not Allowed) (RFA-AR-19-027)

Deadline March 20, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-027.html

 

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites

(UH2/UH3 Clinical Trial Optional) (RFA-AR-19-028) – Deadline March 20, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-028.html

 

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials

(UG3/UH3 Clinical Trial Required) (RFA-AR-19-029) – Deadline February 26, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-029.html

 

HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce

Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) (RFA-AT-19-004)

Deadline February 08, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-004.html

 

Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic

Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required) (RFA-AT-19-005)

Deadline March 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-005.html

 

HEAL Initiative: Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve

Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33 Clinical Trial Optional)

(RFA-AT-19-006) – Deadline February 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-006.html

 

HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance

Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid

Use Disorders (R01, Clinical Trials Optional) (RFA-AT-19-007) – Deadline March 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-007.html

 

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic

(R43/R44 - Clinical Trial Optional) (RFA-DA-19-019) – Deadline April 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-019.html  

 

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic

(R41/R42 - Clinical Trial Optional) (RFA-DA-19-020) – Deadline April 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-020.html

 

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced

Analytics Resource Center (U2C Clinical Trial Not Allowed) (RFA-DA-19-023)

Deadline February 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-023.html

 

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation

Center (U2C Clinical Trial Optional) (RFA-DA-19-024) – Deadline February 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-024.html

 

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers

(UG1 Clinical Trial Optional) (RFA-DA-19025) – Deadline February 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-025.html

 

HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older

Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed) (RFA-DA-19-024)

Deadline March 13, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-034.html

 

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630)

(UG3/UH3 Clinical Trial Required) (RFA-DA-19-035) – Deadline March 13, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-035.html

 

NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce

(UE5 Clinical Trials Not Allowed) (RFA-DE-19-007) – Deadline May 30, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-19-007.html

 

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The

Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial

Required) (RFA-DK-18-030) – Deadline March 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-030.html

 

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The

Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center

(U01 Clinical Trial Required) (RFA-DK-18-031) – Deadline March 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-031.html

 

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)

(RFA-EB-18-003) – Deadline March 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-18-003.html

 

Contraception Research Centers Program (U54 Clinical Trial Optional) (RFA-HD-19-023)

Deadline February 13, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-023.html  

HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not

Allowed) (RFA-HD-19-025) – Deadline March 29, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-025.html

 

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder

(OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)

(RFA-HL-19-028) – Deadline February 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-028.html

 

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder

(OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)

(RFA-HL-19-029) – Deadline February 27, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-029.html

 

HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative

Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical

Trial Required) (RFA-MH-19-525) – Deadline April 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-525.html

 

Center Without Walls for PET Ligand Development for Alzheimer's Disease Related Dementias (ADRDs)

(U19 Clinical Trial Optional) (RFA-NS-19-014) – Deadline February 13, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-014.html

 

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) (RFA-NS-19-016)

Deadline March 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-016.html

 

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional) (RFA-NS-19-017)

Deadline March 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-017.html

 

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional) (RFA-NS-19-018)

Deadline March 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-018.html

 

HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain

(U44 Clinical Trial Not Allowed) (RFA-NS-19-020) – Deadline March 6, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-020.html

 

HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and

Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (RFA-NS-19-021)

Deadline February 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-021.html

 

HEAL Initiative: Early Phase Pain Investigation Clinical Network - Clinical Coordinating Center

(U24 Clinical Trial Not Allowed (RFA-NS-19-023) – Deadline February 6, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-023.html

 

HEAL Initiative: Early Phase Pain Investigation Clinical Network - Data Coordinating Center

(U24 Clinical Trials Not Allowed) (RFA-NS-19-024) – Deadline February 6, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-024.html  

HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers

(U24 Clinical Trial Not Allowed) (RFA-NS-19-025) – Deadline February 6, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-025.html

 

HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and

Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)

(RFA-RM-19-001) – Deadline February 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-001.html

 

HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical

Trial Not Allowed) (RFA-TR-19-003) – Deadline February 28, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-19-003.html

 

HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and

Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed) (RFA-TR-19-005)

Deadline February 28, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-19-005.html

 

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-19-098)

Deadline November 7, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-098.html

 

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative

Innovation Award, (U01 Clinical Trial Optional) (PAR-19-099) – Deadline March 8, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-099.html

 

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory

Collaborative Innovation Awards (R21 Clinical Trial Optional) (PAR-19-100) – Deadline March 8, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-100.html

 

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP)

(U01 Clinical Trial Optional) (PAR-19-101) – Deadline January 30, 2019 and July 30, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-101.html

 

Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) (PAR-19-102)

Deadline May 21, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-102.html

 

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller

Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) (PAR-19-104)

Deadline February 21, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-104.html

 

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers

(K99/R00 - Independent Clinical Trial Not Allowed) (RFA-CA-19-029) – Deadline February 26, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-029.html

 

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers

(K99/R00 - Independent Clinical Trial Required) (RFA-CA-19-030) – Deadline February 26, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-030.html

 

Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders

(UG1 Clinical Trial Required) (RFA-DA-19-018) – Deadline March 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-018.html

 

Human Islet Research Network - Consortium on Modeling Autoimmune Interactions (HIRN-CMAI)

(U01 Clinical Trial Not Allowed) (RFA-DK-18-013) – Deadline February 26, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-013.html

 

Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)

(RFA-EB-18-004) – Deadline February 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-18-004.html

 

NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual

System (R21 Clinical Trial Not Allowed) (RFA-EY-19-001) – Deadline March 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-19-001.html

 

Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure

Prophylaxis (PrEP) Delivery (R01 Clinical Trial Optional) (RFA-MH-19-425) – Deadline February 18, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-425.html

 

NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)

(RFA-OD-19-014) – Deadline March 19, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-014.html

 

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) (PA-19-111)

Deadline February 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-111.html

 

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) (PA-19-112)

Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-112.html

 

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical

Trial Required) (PA-19-116) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-116.html

 

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical

Trial Not Allowed) (PA-9-117) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-117.html

 

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical

Trial Required) (PA-19-118) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-118.html

 

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical

Trial Not Allowed) (PA-19-119) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-119.html

 

Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial

Required) (PA-19-121) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-121.html

 

Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial

Not Allowed) (PA-19-122) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-122.html

 

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not

Allowed) (PA-19-124) - Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-124.html

 

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)

(PA-19-125) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-125.html

 

Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

(PA-19-126) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-126.html

 

Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)

(PA-19-127) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-127.html

 

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)

(PA-19-129) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-129.html

 

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

(PA-9-130) – Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-130.html

 

Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) (PA-19-131)

Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-131.html

 

Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) (PA-19-132)

Deadline February 12, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-132.html

 

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for

Cancer Research (R01 Clinical Trial Optional) (PAR-19-113) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-113.html

 

Non-Human Primates Facilities to Support HIV/AIDS-Related Research (C06 Clinical Trial Not Allowed)

(PAR-19-114) – Deadline March 6, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-114.html

 

Biomedical Research Facilities (C06 Clinical Trial Not Allowed) (PAR-19-128) – Deadline March 4, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-128.html

 

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial

Required) (PAR-19-133) – Deadline February 25, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-133.html  

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools

(R15 Clinical Trial Not Allowed) (PAR-19-1340 – Deadline February 25, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-134.html

 

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools

(R15 Clinical Trial Required) (PAR-19-135) – Deadline February 25, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-135.html

 

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses

(R01 Clinical Trial Optional) (PAR-19-136) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-136.html

 

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

(PAS-19-105) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAS-19-105.html

 

 

OTHER DEADLINES

 

David Geffen School of Medicine at UCLA – The Switzer Prize – Deadline February 28, 2019

https://medschool.ucla.edu/nomination-process

 

Melanoma Research Alliance (MRA) and American Cancer Society (ACS) - Understanding and Managing

Metastasis in Melanoma and Other

Deadline:  Letter of Intent (required) due January 16, 2019 and Full Proposal Deadline is April 15, 2019

https://www.cancer.org/content/cancer/en/research/we-fund-cancer-research/apply-research-grant/grant-types/rfa-metastasis-in-melanoma-and-other-grants.html?org=1459&lvl=100&ite=211&lea=51309&ctr=0&par=1&trk=a1N2M00000KJJXQUA5

 

Print